DI VIRGILIO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 23.526
EU - Europa 7.159
AS - Asia 3.772
OC - Oceania 41
SA - Sud America 33
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 9
Totale 34.556
Nazione #
US - Stati Uniti d'America 23.488
CN - Cina 2.140
DE - Germania 1.965
UA - Ucraina 1.575
IT - Italia 1.344
TR - Turchia 979
GB - Regno Unito 668
SG - Singapore 389
FI - Finlandia 377
SE - Svezia 358
RU - Federazione Russa 333
PL - Polonia 241
FR - Francia 88
ID - Indonesia 71
BE - Belgio 59
VN - Vietnam 57
HK - Hong Kong 41
AU - Australia 35
CA - Canada 31
RO - Romania 24
IE - Irlanda 20
IR - Iran 20
BR - Brasile 19
IN - India 19
CZ - Repubblica Ceca 15
JP - Giappone 15
CH - Svizzera 14
ES - Italia 14
NL - Olanda 14
DK - Danimarca 11
EU - Europa 11
KR - Corea 9
IL - Israele 8
GR - Grecia 7
MX - Messico 7
IQ - Iraq 6
NZ - Nuova Zelanda 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BD - Bangladesh 5
EG - Egitto 5
AR - Argentina 4
AT - Austria 4
BG - Bulgaria 4
EC - Ecuador 4
LU - Lussemburgo 4
MD - Moldavia 4
AM - Armenia 3
CO - Colombia 3
EE - Estonia 3
HR - Croazia 3
PT - Portogallo 3
TW - Taiwan 3
CL - Cile 2
DZ - Algeria 2
LT - Lituania 2
SA - Arabia Saudita 2
BN - Brunei Darussalam 1
GE - Georgia 1
HU - Ungheria 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 34.556
Città #
Fairfield 3.221
Woodbridge 3.031
Houston 2.106
Jacksonville 1.824
Chandler 1.735
Ann Arbor 1.603
Ashburn 1.419
Wilmington 1.201
Seattle 1.150
Cambridge 941
Izmir 684
Nanjing 532
Ferrara 492
Princeton 441
Beijing 364
Boardman 299
San Diego 289
Warsaw 225
Singapore 222
Addison 209
Shanghai 195
Nanchang 150
New York 147
Shenyang 146
Milan 140
Dearborn 134
Bremen 115
Hebei 107
Tianjin 99
Jiaxing 96
Redwood City 86
Changsha 75
Jakarta 70
Mountain View 68
Norwalk 67
Falls Church 57
Brussels 56
Dong Ket 56
Zhengzhou 53
Jinan 50
Los Angeles 48
San Mateo 48
London 46
Kunming 42
Ningbo 39
Guangzhou 37
Munich 35
Orange 35
Hong Kong 34
Rome 34
Auburn Hills 32
Helsinki 32
Des Moines 30
Indiana 30
Chicago 27
Tappahannock 27
Augusta 26
Washington 25
Bologna 24
Taizhou 24
Hangzhou 23
Padova 21
Philadelphia 20
Verona 20
Redmond 18
Catania 16
Lanzhou 16
Monmouth Junction 16
Haikou 15
Kilburn 13
Leawood 13
Lappeenranta 12
Rovereto 12
Montréal 10
Changchun 9
Copenhagen 9
Ferrara di Monte Baldo 9
San Francisco 9
Ardabil 8
Brno 8
Hefei 8
Napoli 8
Walnut 8
Dublin 7
Hounslow 7
Ottawa 7
Pescara 7
Vicenza 7
Acton 6
Berkeley 6
Calvisano 6
Chiswick 6
Fuzhou 6
Menlo Park 6
Saint Albans 6
Salerno 6
Sheffield 6
Tel Aviv 6
Wandsworth 6
Andover 5
Totale 25.037
Nome #
P2X7 receptor involvement in the pathogenesis of Hidradenitis Suppurativa 301
I recettori purinergici P2 e le ectonucleotidasi: nuovi bersagli per lo sviluppo di farmaci anti-tumorali/P2 purinergic receptors and ectonucleotidases: novel targets for anti-cancer drugs (FIRB Accordi di programma n. RBAP11FXBC) 226
Il recettore purinergico P2X7 come modulatore della fisiologia mitocondriale e del processo apoptotico 197
IL PROCESSO INFIAMMATORIO 180
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 174
P2X7 targeting inhibits growth of human mesothelioma 171
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. 165
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 154
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 152
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 151
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 150
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 148
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP 147
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 143
p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner 141
Purinergic signaling in the immune system 139
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 137
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 137
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 136
Silencing of P2X7 receptor reduces B16 melanoma growth both in vitro and in vivo 135
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 134
Extracellular purines, purinergic receptors and tumor growth 134
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 133
Role of P2X7 receptor in host response to melanoma 132
The antibiotic polymyxin B modulates P2X7 receptor function 130
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 129
Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis 129
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 129
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 128
The P2X7 receptor is a key modulator of aerobic glycolysis. 127
The P2X7 receptor: a key player in IL-1 processing and release 127
Expression of P2X7 receptor increases in vivo tumor growth 127
Purinoceptor function in the immune system 125
The P2X7 receptor-interleukin-1 liaison 125
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 125
Increased level of extracellular ATP at tumor sites: In vivo imaging with plasma membrane luciferase 124
Stimulation of Purinergic Receptors Modulates Chemokine Expression in Human Keratinocytes 124
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 123
Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity 122
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation 122
The antibiotic polymyxin B modulates P2X7 receptor function 122
Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors 122
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 120
Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation 120
P2 receptors in cancer progression and metastatic spreading 120
ATP-mediated cytotoxicity in microglial cells 119
Purinergic regulation of airway inflammation 117
La stimolazione del recettore P2X7 causa il rilascio di microvescicole contenenti IL-1 beta da parte di cellule dendritiche umane 116
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 116
Activation of muscarinic receptors in PC12 cells. Correlation between cytosolic Ca2+ rise and phosphoinositide hydrolysis. 116
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 116
Activation of human eosinophils via P2 receptors: novel findings and future perspectives 115
Insight on P2X7 receptor role as oncogene 115
null 115
Extracellular nucleotides and nucleosides as signalling molecules 115
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 113
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 113
The P2X7 Receptor in Infection and Inflammation 112
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels 112
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 112
null 111
null 111
The human cathelicidin LL-37 modulates the activities of the P2X 7 receptor in a structure-dependent manner 111
Sidedness of e− Donation and Stoichiometry of H+ Pumps at Sites II + III in Mitochondria from Rat Liver 110
Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma 110
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells 109
Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. 109
Activation of muscarinic receptors in PC12 cells. Stimulation of Ca2+ influx and redistribution. 109
P2 purinoceptors in the immune system 109
Idiopatic inflammatory myopathies: serological and clinical correlations. Analysis of a monocentric series 109
Role of the P2X7 receptor in tumor-associated inflammation 109
5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes 108
Purinergic P2Y(2) Receptors Promote Neutrophil Infiltration and Hepatocyte Death in Mice With Acute Liver Injury 108
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 108
Acute myeloid leukaemia:analysis of the expression of P2X7a and P2X7B isoforms 108
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. 107
Dysfunctional inflammasome in Schnitzler's syndrome 107
P2X7A and B as novel biomarkers of acute myeloid leukemia response to chemotherapy and innovative therapeutic targets for the disease 107
Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. 106
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X(7)-receptor containing a tyrosine moiety 106
Cell-mediated cytotoxicity: ATP as an effector and the role of target cells 106
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease 106
Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels. 105
Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+. 105
The P2X7 receptor : from ion channel to oncogene 105
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 105
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 104
The Serotoninergic Receptors of Human Dendritic Cells: Identification and Coupling to Cytokine Release 104
P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production 104
Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes 104
ATP receptors and giant cell formation 104
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 104
P2X7 Receptor Expression in Patients With Serositis Related to Systemic Lupus Erythematosus 104
Liaisons dangereuses: P2X7 and the inflammasome 103
P2X7 receptor and polykarion formation 103
null 103
The sixth sense: hematopoietic stem cells detect danger through purinergic signaling 103
intracellular calcium handling by fibroblasts from non insulin dependent diabetic patients with and without hypertension and microalbuminuria 103
Molecular machinery and signaling events in apoptosis 103
Purinergic signalling between axons and microglia 102
Totale 12.411
Categoria #
all - tutte 140.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.186
Totale 143.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.370 1.206 246 230 1.083 503 907 653 776 612 673 311 170
2020/20215.249 457 432 230 571 286 530 223 597 202 659 703 359
2021/20224.501 123 468 260 157 278 213 237 250 197 356 434 1.528
2022/20234.150 486 173 139 487 685 598 123 447 540 53 280 139
2023/20242.128 235 314 91 62 189 262 91 145 47 49 93 550
2024/202524 24 0 0 0 0 0 0 0 0 0 0 0
Totale 35.222